Theralase Technologies (TLT) News Today C$0.22 +0.01 (+4.76%) As of 08/8/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesBuy This Stock TLT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Theralase Technologies Inc. (TLT.V) - Yahoo FinanceJuly 13, 2025 | finance.yahoo.comTheralase Technologies Extends Warrant Expiry to 2028June 30, 2025 | tipranks.comTheralase Technologies (CVE:TLT) Sets New 52-Week High - Here's What HappenedJune 23, 2025 | marketbeat.comMultiple insider buying at Theralase Technologies (TLT)June 20, 2025 | theglobeandmail.comTheralase Completes $CAN 571,000 Private Placement to Advance Cancer ResearchJune 17, 2025 | tipranks.comTheralase Technologies Inc.: Theralase Completes Annual General and Special MeetingJune 12, 2025 | finanznachrichten.deTheralase Completes Annual General and Special MeetingJune 12, 2025 | finance.yahoo.comTheralase Annual General MeetingJune 5, 2025 | finance.yahoo.comTheralase Technologies Inc.: Theralase Annual General MeetingJune 5, 2025 | finanznachrichten.deCORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025May 30, 2025 | theglobeandmail.comTheralase(R) 1Q2025 Financial StatementsMay 30, 2025 | finance.yahoo.comTheralase to Present Groundbreaking Research at ASTRO 2025May 29, 2025 | seekingalpha.comTheralase Technologies Inc.: Theralase to Present Groundbreaking Research at ASTRO 2025May 29, 2025 | finanznachrichten.deTheralase Provides Corporate UpdateMay 20, 2025 | finance.yahoo.comTheralase Technologies Inc.May 12, 2025 | investing.comTheralase Technologies Inc.: Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological AssociationMay 5, 2025 | finanznachrichten.deTheralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological AssociationMay 5, 2025 | finance.yahoo.comTheralase uncovers new use-case for flagship drugApril 28, 2025 | msn.comTheralase Discovers New Mechanism of Action of Lead DrugApril 28, 2025 | markets.businessinsider.comTheralase Technologies Secures $CAN 419,124 in Private Placement to Boost Cancer and Virus ResearchApril 14, 2025 | tipranks.comRuvidar More Effective in the Treatment of Herpes than FDA-Approved TreatmentsApril 10, 2025 | markets.businessinsider.comRuvidar Demonstrates 7 Year Complete ResponseApril 7, 2025 | markets.businessinsider.comRuvidar Effective in the Treatment of HerpesMarch 24, 2025 | markets.businessinsider.comTheralase's Ruvidar excels in preclinical herpes treatmentMarch 24, 2025 | msn.comTheralase Technologies Inc. (TLTFF) Q4 2024 Earnings Call TranscriptMarch 19, 2025 | seekingalpha.comTheralase Technologies Full Year 2024 Earnings: Beats ExpectationsMarch 16, 2025 | finance.yahoo.comTheralase Technologies (CVE:TLT) Stock Price Down 10.6% - Here's What HappenedMarch 13, 2025 | marketbeat.comTheralase(R) Releases 2024 Annual Financial StatementsMarch 12, 2025 | markets.businessinsider.comTheralase Technologies Secures $CAN 310,200 in Private Placement to Boost Cancer ResearchMarch 11, 2025 | tipranks.comTheralase(R) Therapy Improves Motor and Non-Motor Function in Parkinson's PatientsMarch 10, 2025 | markets.businessinsider.comTheralase Technologies (CVE:TLT) Trading 3.5% Higher - Time to Buy?February 19, 2025 | marketbeat.comTheralase Technologies, Inc.: CORRECTING AND REPLACING: Theralase Demonstrates Effective Treatment of HerpesFebruary 13, 2025 | finanznachrichten.deTheralase Technologies, Inc.: Theralase Demonstrates Effective Treatment of HerpesFebruary 12, 2025 | finanznachrichten.deTheralase(R) Releases Latest Research on Inactivation of Herpes Simplex VirusesFebruary 11, 2025 | theglobeandmail.comTheralase achieves breakthrough Herpes treatmentFebruary 10, 2025 | msn.comTheralase Technologies, Inc.: Theralase Releases Latest Research on Inactivation of Herpes Simplex VirusesFebruary 10, 2025 | finanznachrichten.deTheralase Technologies (CVE:TLT) Trading Up 14.3% - Still a Buy?January 28, 2025 | marketbeat.comTheralase Technologies (CVE:TLT) Trading Up 10.2% - What's Next?January 28, 2025 | marketbeat.comTheralase’s Innovative Bladder Cancer Treatment to be Highlighted at AUA Annual MeetingJanuary 27, 2025 | msn.comTheralase Technologies, Inc.: Theralase Interim Clinical Data to be Presented at the 2025 AUA Annual MeetingJanuary 27, 2025 | finanznachrichten.deTheralase Technologies (CVE:TLT) Stock Price Down 1.6% - Here's WhyJanuary 10, 2025 | marketbeat.comTheralase Technologies (CVE:TLT) Shares Down 7.4% - Here's WhyDecember 20, 2024 | marketbeat.comTheralase(R) Launches New Clinical Study Site in CanadaDecember 5, 2024 | stockhouse.comTheralase Technologies Inc. (TLTFF) Q3 2024 Earnings Call TranscriptDecember 5, 2024 | seekingalpha.comTheralase Technologies Extends Warrant Expiry DateNovember 13, 2024 | markets.businessinsider.comTheralase Technologies Inc. (TLT.V)October 27, 2024 | ca.finance.yahoo.comTheralase Technologies (CVE:TLT) Trading Down 15.8% - Time to Sell?October 22, 2024 | marketbeat.comTheralase Technologies (CVE:TLT) Shares Up 21.1% - What's Next?October 21, 2024 | marketbeat.comThree Canadian small-caps stocks for a contrarian investmentOctober 11, 2024 | msn.comLatest data from bladder cancer study to propel future growthOctober 10, 2024 | msn.com Get Theralase Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for TLT and its competitors with MarketBeat's FREE daily newsletter. Email Address TLT Media Mentions By Week TLT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLT News Sentiment▼0.000.38▲Average Medical News Sentiment TLT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLT Articles This Week▼01▲TLT Articles Average Week Get Theralase Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for TLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Quipt Home Medical News VentriPoint Diagnostics News MedX Health News Aurora Spine News Profound Medical News Cardiol Therapeutics News Theratechnologies News BioSyent News Zentek News Oncolytics Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:TLT) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theralase Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theralase Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
